- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 4.42M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.2M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.46M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.68M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $10.62M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $15.08M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $17.01M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.65M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $11.77M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $14.49M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $14.79M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 4.38M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $28K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$58K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$54.77M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$55.54M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.16 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.16 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.24M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $137K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $708K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $1.11M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $6.31M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $3.87M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $10.18M |